The STROBE reporting guideline for writing up observational studies in epidemiology
How to use this reporting guideline
You can use reporting guidelines throughout your research process.
- When writing: Consider using a writing guide to draft your manuscript or protocol.
- After writing: Complete a checklist and include it with your journal submission.
- To learn: Consult the guidance whenever you need it.
However you use STROBE, please cite it.
Applicability criteria
Summary of guidance
Although you should describe all items below, you can decide how to order and prioritize items most relevant to your study, findings, context, and readership whilst keeping your writing concise. You can read how STROBE was developed in the FAQs.
Item name | What to write |
Title and abstract | |
1a. Indicate the study’s design | Indicate the study’s design with a commonly used term in the title or the abstract. |
1b. Abstract | Provide in the abstract an informative and balanced summary of what was done and what was found. |
Introduction | |
2. Background / rationale | Explain the scientific background and rationale for the investigation being reported. |
3. Objectives | State specific objectives, including any prespecified hypotheses. |
Methods | |
4. Study design | Present key elements of study design early in the paper. |
5. Setting | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection. |
6a. Eligibility criteria | Cohort study: Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up. Case-control study: Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls. Cross-sectional study: Give the eligibility criteria, and the sources and methods of selection of participants. |
6b. Matching criteria | Cohort study: For matched studies, give matching criteria and number of exposed and unexposed. Case-control study: For matched studies, give matching criteria and the number of controls per case. |
7. Variables | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable. |
8. Data sources / measurement | For each variable of interest give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group. |
9. Bias | Describe any efforts to address potential sources of bias. |
10. Study size | Explain how the study size was arrived at. |
11. Quantitative variables | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen, and why. |
12a. Statistical methods | Describe all statistical methods, including those used to control for confounding. |
12b. Statistical methods – subgroups and interactions | Describe any methods used to examine subgroups and interactions. |
12c. Statistical methods – missing data | Explain how missing data were addressed. |
12di. Statistical methods – loss to follow-up | Cohort study: If applicable, describe how loss to follow-up was addressed. |
12dii. Statistical methods – matching cases and controls | Case-control study: If applicable, explain how matching of cases and controls was addressed. |
12diii. Statistical methods – sampling strategy | Cross-sectional study: If applicable, describe analytical methods taking account of sampling strategy. |
12e. Statistical methods – sensitivity analyses | Describe any sensitivity analyses. |
Results | |
13a. Participant numbers | Report the numbers of individuals at each stage of the study—e.g., numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed; Consider use of a flow diagram. |
13b. Participants – non-participation | Give reasons for non-participation at each stage. |
13c. Participants – flow diagram | Consider use of a flow diagram. |
14a. Descriptive data – participant characteristics | Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and potential confounders. Present the information in a table. |
14b. Descriptive data – missing data | Indicate the number of participants with missing data for each variable of interest. |
14c. Descriptive data – follow-up time | Cohort study: Summarise follow-up time—e.g., average and total amount. |
15. Outcome data | Cohort study: Report numbers of outcome events or summary measures over time. Case-control study: Report numbers in each exposure category, or summary measures of exposure. Cross-sectional study: Report numbers of outcome events or summary measures. |
16a. Main results | Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g., 95% confidence intervals). Make clear which confounders were adjusted for and why they were included. |
16b. Main results – category boundaries | Report category boundaries when continuous variables were categorised. |
16c. Main results – risk | If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period. |
17. Other analyses | Report other analyses done—e.g., analyses of subgroups and interactions, and sensitivity analyses. |
Discussion | |
18. Key results | Summarise key results with reference to study objectives. |
19. Limitations | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias. |
20. Interpretation | Give a cautious overall interpretation considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence. |
21. Generalisability | Discuss the generalisability (external validity) of the study results. |
Other information | |
22. Funding | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based. |
We like publishing transparent research because we think it’s more likely to be used and cited. That’s why we ask authors to use reporting guidelines.
Robin Lavery
Editor, International Journal of World Medicine
Ready to get started?
Cohort_studies
In cohort studies, the investigators follow people over time. They obtain information about people and their exposures at baseline, let time pass, and then assess the occurrence of outcomes. Investigators commonly make contrasts between individuals who are exposed and not exposed or among groups of individuals with different categories of exposure. Investigators may assess several different outcomes, and examine exposure and outcome variables at multiple points during follow-up. Closed cohorts (for example birth cohorts) enrol a defined number of participants at study onset and follow them from that time forward, often at set intervals up to a fixed end date. In open cohorts the study population is dynamic - people enter and leave the population at different points in time (for example inhabitants of a town). Open cohorts change due to deaths, births, and migration, but the composition of the population with regard to variables such as age and gender may remain approximately constant, especially over a short period of time. In a closed cohort cumulative incidences (risks) and incidence rates can be estimated; when exposed and unexposed groups are compared, this leads to risk ratio or rate ratio estimates. Open cohorts estimate incidence rates and rate ratios.
Case_control_studies
In case-control studies, investigators compare exposures between people with a particular disease outcome (cases) and people without that outcome (controls). Investigators aim to collect cases and controls that are representative of an underlying cohort or a cross-section of a population. That population can be defined geographically, but also more loosely as the catchment area of health care facilities. The case sample may be 100% or a large fraction of available cases, while the control sample usually is only a small fraction of the people who do not have the pertinent outcome. Controls represent the cohort or population of people from which the cases arose. Investigators calculate the ratio of the odds of exposures to putative causes of the disease among cases and controls (see Item 16c). Depending on the sampling strategy for cases and controls and the nature of the population studied, the odds ratio obtained in a case-control study is interpreted as the risk ratio, rate ratio or (prevalence) odds ratio1,2. The majority of published case-control studies sample open cohorts and so allow direct estimations of rate ratios.
Cross-sectional_studies
In cross-sectional studies, investigators assess all individuals in a sample at the same point in time, often to examine the prevalence of exposures, risk factors or disease. Some cross-sectional studies are analytical and aim to quantify potential causal associations between exposures and disease. Such studies may be analysed like a cohort study by comparing disease prevalence between exposure groups. They may also be analysed like a case-control study by comparing the odds of exposure between groups with and without disease. A difficulty that can occur in any design but is particularly clear in cross-sectional studies is to establish that an exposure preceded the disease, although the time order of exposure and outcome may sometimes be clear. In a study in which the exposure variable is congenital or genetic, for example, we can be confident that the exposure preceded the disease, even if we are measuring both at the same time.